methylene blue has been researched along with Cognitive Decline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baddeley, TC; Bentham, P; Bracoud, L; Ganesan, H; Gauthier, S; Hammel, J; Harrington, CR; Jia, J; Kook, K; Murray, AD; Riedel, G; Rubino, CM; Schelter, BO; Shiells, H; Staff, RT; Storey, JMD; Vuksanovic, V; Wischik, CM | 1 |
| Beauchet, O; Flores, J; LeBlanc, AC; Noël, A; Sjöström, PJ; Zhou, L | 1 |
| Chang, J; Chen, C; Chen, M; Chen, T; Fang, P; Zhang, Z; Zheng, F; Zhong, Q | 1 |
| Bartochowski, Z; Grossberg, GT; Hashweh, NN; Khoury, R | 1 |
| Deng, Y; Li, S; Wang, R; Wang, T; Wu, J; Zhang, J; Zhu, X | 1 |
| Arias, JL; Arias, N; Fidalgo, C; Méndez, M | 1 |
| Auchter, A; Barksdale, B; Gonzalez-Lima, F; Monfils, MH; Williams, J | 1 |
| Alda, M; Blagdon, R; Dursun, S; Garnham, J; Hajek, T; MacLellan, S; MacQueen, G; McKinnon, M; Nair, C; O'Donovan, C | 1 |
1 review(s) available for methylene blue and Cognitive Decline
| Article | Year |
|---|---|
An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Humans; Methylene Blue; Protein Aggregates; Randomized Controlled Trials as Topic; tau Proteins; Treatment Outcome | 2020 |
3 trial(s) available for methylene blue and Cognitive Decline
| Article | Year |
|---|---|
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Cognitive Dysfunction; Dose-Response Relationship, Drug; Female; Humans; Male; Methylene Blue | 2019 |
Methylene blue reduces incidence of early postoperative cognitive disorders in elderly patients undergoing major non-cardiac surgery: An open-label randomized controlled clinical trial.
Topics: Aged; Cognition; Cognitive Dysfunction; Humans; Incidence; Methylene Blue; Postoperative Complications; Prospective Studies | 2021 |
Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study.
Topics: Adult; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Cross-Over Studies; Depression; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Humans; Lamotrigine; Male; Methylene Blue; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Triazines; Young Adult | 2017 |
4 other study(ies) available for methylene blue and Cognitive Decline
| Article | Year |
|---|---|
Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice.
Topics: Aging; Animals; Caspase 6; Caspase Inhibitors; Cognitive Dysfunction; Female; Humans; Inflammation; Male; Methylene Blue; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic | 2019 |
Methylene Blue Protects Against Sevoflurane-Induced Cognitive Dysfunction by Suppressing Drp1 deSUMOylation in Aged Mice.
Topics: Anesthetics, Inhalation; Animals; Cognitive Dysfunction; Cysteine Endopeptidases; Dynamins; Hippocampus; Male; Methylene Blue; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Sevoflurane; Sumoylation | 2020 |
Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Electron Transport Complex IV; Enzyme Inhibitors; Hepatic Encephalopathy; Hippocampus; Low-Level Light Therapy; Male; Methylene Blue; Neostriatum; Prefrontal Cortex; Rats, Wistar | 2021 |
Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion.
Topics: Analysis of Variance; Animals; Association Learning; Cognitive Dysfunction; Coronary Occlusion; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Locomotion; Male; Methylene Blue; Motor Activity; Odorants; Rats; Rats, Long-Evans; Recognition, Psychology | 2014 |